Full Breakdown
Rise in Cannabis Use Disorder Among U.S. Adults Highlights Growing Public-Health Concern
8/24/2026, 9:58:02 PM
Core Findings of the New NIDA Study
A recent study conducted by the National Institute on Drug Abuse (NIDA) reports that cannabis use disorder (CUD) has risen sharply among U.S. adults. In 2024, the study estimates that 9.3 % of adult men and 5.6 % of adult women meet criteria for CUD, indicating that their lives are negatively affected by cannabis and they struggle to cut back or quit. Among 18- to 20-year-olds, the prevalence of CUD now exceeds that of alcohol use disorder, marking the first time this age group shows a higher rate for cannabis than for alcohol.
Background and Contributing Factors
The study’s senior author, Dr. Nora Volkow, director of NIDA, emphasizes that the rise is not solely due to increased overall consumption. She points to the proliferation of high-potency cannabis products that deliver very high doses of tetrahydrocannabinol (THC). According to Dr. This observation challenges the long-standing perception that cannabis is non-addictive. Earlier reporting by local outlets had already noted growing concerns among Massachusetts youth-addiction and mental-health providers about severe outcomes such as cannabis-induced psychosis.
Key Data and Statistics
- Adult men with CUD: 9.3 % (2024)
- Adult women with CUD: 5.6 % (2024)
- Severe CUD: prevalence also increased, though exact figures were not disclosed.
- Young adults (18-20): CUD prevalence now surpasses alcohol use disorder prevalence.
Official Statements and Policy Response
Dr. Volkow told interviewers that the study’s findings challenge misconceptions about cannabis addiction and that the similarity between CUD and alcohol-use disorder rates is incredibly worrisome. In response to the emerging data, Massachusetts’ Cannabis Control Commission received a $1 million allocation in the recent state budget for a public-education campaign aimed at informing residents about CUD and its risks.
Public-Health Implications
The convergence of CUD rates with those of alcohol use disorder suggests a potential shift in the nation’s substance-use landscape. Higher-potency products may elevate both addiction risk and associated medical problems, prompting calls for increased awareness, prevention efforts, and possibly regulatory review of THC concentrations in consumer products. The state-level education funding represents an early policy step, but the broader trend underscores the need for continued research and public-health strategies to mitigate the growing impact of cannabis addiction.
